Fiduciary Management, Inc.’s Q1 2026 Investor Letter
Fiduciary Management, Inc. (FMI) released its Q1 2026 investor letter, noting that the Iran war triggered a sharp sell‑off in global equities. The S&P 500 fell 4.33% and MSCI World dropped 3.57%, while the Russell 2000 and MSCI EAFE slipped 0.89% and 1.24% respectively. FMI’s portfolio remains focused on high‑quality businesses at discounts, but its underweight stance in energy and defense contrasted with those sectors’ outperformance. The letter also spotlights the firm’s top five holdings for 2026.
Jefferies Updates Elevance Health, Inc. (ELV) Forecasts After Deeper Analysis of Exchange Segment Dynamics
Jefferies analyst David Windley trimmed Elevance Health’s (ELV) price target to $391 from $395, citing a deeper review of the health‑insurance exchange segment. The revision accompanies updated financial forecasts that reflect refined assumptions about managed‑care plan dynamics. In March, Elevance...
Jefferies Adjusts The Cigna Group (CI) Target Lower After Health Insurance Exchange Review
Jefferies reaffirmed its Buy rating on Cigna (CI) but trimmed its price objective from $333 to $330 after a detailed review of Health Insurance Exchange plan offerings, signaling a modest valuation adjustment for the managed‑care giant. The Cigna Foundation simultaneously...
Evercore ISI Says Sun Pharma Deal Talk for Organon & Co. (OGN) Lacks Confirmation, Remains Speculative
Evercore ISI said media reports of a potential $12 billion Sun Pharmaceutical offer for Organon & Co. are speculative and lack confirmation. The firm emphasized that the rumor does not constitute a confirmed transaction. Separately, Organon’s VTAMA (tapinarof) 1% cream received...
Bio-Rad Laboratories, Inc. (BIO) PT Reduced to $300 by Citigroup Amid Process Chromatography Concerns
Citigroup lowered Bio‑Rad Laboratories’ (NYSE:BIO) rating from Buy to Neutral on April 7, cutting its price target to $300 from $375. The downgrade stems from doubts that the company’s process chromatography segment can regain strong growth or margin expansion, a key...
Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1
Truist Financial trimmed its price target for Inspire Medical Systems (INSP) to $64 from $70, while keeping a Hold stance, as part of a broader MedTech outlook ahead of the company’s Q1 earnings. A day earlier, Royal Bank of Canada...
10 Best US Stocks to Invest In for Long Term
Market volatility sparked by the Iran conflict and slowing U.S. growth has investors seeking safe, long‑term equity plays. Financial advisors are urging a cash buffer of 2‑10% of portfolios while maintaining diversified holdings. Capital Group’s CEO highlighted the need to...
5 Best US Stocks to Invest In for Long Term
Corning Incorporated (NYSE:GLW) is highlighted as a top long‑term U.S. stock, backed by 85 hedge‑fund holders. Morgan Stanley raised its price recommendation to $140 from $127, keeping an Equal Weight rating, while JPMorgan downgraded the stock to Neutral but lifted...
Why Eaton (ETN) May Be Positioned For More Than Just A Strong Quarter
Eaton Corp (ETN) saw its price target raised by Citi to $464 from $435, keeping a Buy rating as industrial demand steadies. The firm also announced a $30 million investment to build a new medium‑voltage switchgear plant near Omaha, targeting the...
ARM Stock Raised to $210 — And Analysts See More Than Smartphones
Analysts have upgraded their price targets for Arm Holdings, with Susquehanna International Group lifting its target to $210 and Goldman Sachs raising its target to $125, though the latter maintains a Sell rating. Both firms cite the company's expanding total...
Here Is Why Linde Plc (LIN) Is Among the Best European Stocks to Buy According to Analysts
Linde plc (NASDAQ:LIN) has been highlighted as one of the ten best European stocks to buy, after analysts raised their price targets in mid‑April. Seaport Research Partners lifted its target to $575, up from $525, while Citigroup lifted its target...
Amplitude (AMPL) Slipped Amid Broad Software Selloff
Amplitude Inc. (NASDAQ:AMPL) saw its stock dip to $7.08, a 10.8% decline, even as it posted a 4.9% one‑month gain and reported 17% year‑over‑year revenue growth to $91.4 million in Q4 2025. Meridian Small‑Cap Growth Fund highlighted the company as a high‑quality...
Meridian Small Cap Growth Fund’s Q1 2026 Investor Letter
Meridian Funds’ ArrowMark‑managed Small Cap Growth Fund posted a -8.37% return in Q1 2026, trailing the Russell 2000 Growth Index’s -2.82% decline. The fund’s underperformance stemmed mainly from industry‑allocation choices, although stock selection added modest upside. The quarter was marked by heightened...
XPO (XPO) Reported Strong Results in a Challenging Environment
Carillon Tower Advisers’ Q1 2026 investor letter highlighted XPO, Inc. as a standout mid‑cap growth stock. XPO closed April 20 at $228.37, delivering a 22.56% one‑month gain and a 136.85% rise over the past 52 weeks. The logistics firm posted $2 billion in Q4 2025...
Quanta Services (PWR) Gains From Solid Execution
Carillon Eagle Mid Cap Growth Fund highlighted Quanta Services (PWR) as a standout performer in its Q1 2026 letter, noting a 131% gain over the past 52 weeks and a closing price of $604.97. The energy sector surged 45.23% in...
Teradyne (TER) Surged on Investors’ Favour
Carillon Eagle Mid Cap Growth Fund highlighted Teradyne as a top pick in its Q1 2026 investor letter. Teradyne’s shares closed at $1,154.69, up 17.2% in the past month and 426% over the last year, giving the company a $3.1 billion...
Here’s What Putting Pressure on Ares Management (ARES)
Carillon Tower Advisers’ Q1 2026 letter for the Carillon Eagle Mid‑Cap Growth Fund flagged Ares Management Corp. (NYSE:ARES) as a stock under pressure after a wave of retail redemptions hit its private‑credit platform. Despite the headwinds, the fund praised Ares’ diversified...
Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development
Simulations Plus Inc (NASDAQ:SLP) announced on March 26 that three major pharmaceutical firms have joined its AI‑enabled modeling collaboration programs, embedding the company’s AI agents directly into their drug‑development workflows. The firm emphasized a fully integrated AI deployment rather than...
What’s Schrodinger Inc (SDGR) Working Out with Anthropic?
Schrödinger Inc. announced at the KeyBanc Healthcare Forum that it will move 75% of its software contracts to hosted, cloud‑based models within three years, responding to growing customer demand. The company is also collaborating with Anthropic and other AI firms...
Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership
Recursion Pharmaceuticals announced an expanded partnership with Citeline on March 31, adding the data‑provider’s real‑world evidence capabilities to its AI‑driven drug discovery platform. The integration is designed to improve clinical‑trial design and accelerate decision‑making for its pipeline of cancer and...
Butterfly Network Inc (BFLY): Top Medical AI Stock to Buy
Butterfly Network announced FDA clearance for its AI‑powered handheld ultrasound that estimates gestational age in under two minutes. The AI model was trained on millions of diverse ultrasound images, aiming to improve prenatal care in emergency and rural settings. In...
Here Is Why Lantheus Holdings Inc (LNTH) Is Among the Best Medical AI Stocks to Invest In
Lantheus Holdings (LNTH) has outperformed the market, climbing about 23% year‑to‑date and 46% over the past six months. The company secured FDA approval for its prostate‑cancer imaging agent PYLARIFY TruVu on March 6, while its diagnostic kit LNTH‑2501 remains under extended...
Teladoc Health Inc (TDOC): AI Push Amid Share BuyBack Calls
Teladoc Health is under pressure from activist Pineal Capital, which is demanding a minimum $200 million share‑repurchase program and a split of its Integrated Care and BetterHelp businesses. The company is simultaneously expanding its AI portfolio, adding workplace‑safety and fall‑prevention tools...
Here’s What TD Cowen Thinks About Tempus AI Inc (TEM) Stock
TD Cowen upgraded Tempus AI Inc (NASDAQ:TEM) to a Buy rating, trimming its price target to $65 from $70. The company reported an 83.4% revenue jump to $1.3 billion in 2025 and projects $1.59 billion for 2026, a 25% increase. Strategic partnerships...
Favorable Zio Results Brighten iRhythm Holdings, Inc (IRTC)’s Prospects
iRhythm Holdings presented new clinical data at the ACC 2026 Scientific Sessions showing its Zio patch identified actionable arrhythmias in nearly half of patients with chronic kidney disease and markedly higher atrial fibrillation detection in severely obese individuals. The company...
What Makes Veeva Systems Inc (VEEV)’s Future Bright?
Stifel reaffirmed its Buy rating on Veeva Systems, setting a $245 price target as the firm deepens its AI push in life‑sciences CRM. Veeva recently bought AI‑powered chat platform Ostro for roughly $100 million, positioning the technology as a standalone unit...
Here’s What Piper Sandler Thinks About Boston Scientific Corp (BSX) Now
Piper Sandler reaffirmed its Overweight rating on Boston Scientific (BSX) after the Champion‑AF trial showed the Watchman left‑atrial appendage closure device met all safety and efficacy endpoints. The firm projects Watchman sales to grow 20% annually, contributing roughly 200 basis...
10 Best AI Stock Picks of Motley Fool Asset Management
Motley Fool Asset Management highlighted its ten largest AI‑focused holdings, led by Tesla (≈$66.8 million) and Visa (≈$67.1 million). Its flagship Motley Fool 100 Index ETF (TMFC) generated a 19.97% return for the year, outpacing the S&P 500’s 17.88% gain. The firm stresses...
5 Best AI Stock Picks of Motley Fool Asset Management
Motley Fool Asset Management lists Amazon.com (NASDAQ:AMZN) as one of its five best AI stock picks, holding a $113.64 million stake. The company’s cloud unit, AWS, commands roughly 30‑32% of the global infrastructure market and enjoys 30% operating margins, positioning it...
8 Best Long-Term ASX Stocks to Buy Right Now
Reuters data shows Australian consumer sentiment plunged 12.5% to 80.1 in April, its lowest in two years, while S&P Global Ratings cut ASX Ltd’s credit rating to A+/A‑1 after ASIC flagged governance lapses. Despite the short‑term headwinds, S&P kept a...
5 Best Long-Term ASX Stocks to Buy Right Now
Newmont Corporation (NYSE:NEM) is highlighted as a top long‑term ASX pick despite a recent downgrade by National Bank. The broker cut its rating to “Sector Perform” and lowered the price target to $130, citing higher diesel costs, a new Ghana...
8 Most Undervalued Biotech Stocks to Buy Right Now
The article spotlights eight biotech stocks deemed undervalued, selected via a Finviz screen for forward P/E below 15 and high hedge‑fund ownership as of Q4 2025. It highlights Valneva SE’s €174.7 million (≈$192 million) 2025 revenue, strong cash position of €109.7 million (≈$121 million), and...
5 Most Undervalued Biotech Stocks to Buy Right Now
ADMA Biologics (NASDAQ:ADMA) appears on a list of the five most undervalued biotech stocks, even as Cantor Fitzgerald downgraded the shares to neutral after a short‑seller report alleged channel‑stuffing and rising days‑sales‑outstanding. Cantor highlighted the lack of clear response from...
12 Unstoppable Growth Stocks to Invest In According to Reddit
Tom Lee told CNBC the US market is poised for new highs, citing resilience to oil‑price spikes and war‑driven inflation. Using Reddit threads, Insider Monkey compiled a list of 12 "unstoppable" growth stocks that also enjoy heavy hedge‑fund ownership. The...
Top 10 Utility Stocks to Buy Now
The S&P 500 Utilities index has surged 7% year‑to‑date and 33% over the past 12 months, outpacing the broader market as demand from data centers, electric vehicles and manufacturing fuels growth. Morningstar analysts note that earnings are expected to keep...
Tesla (TSLA): The Best EV Stock to Buy For Long Term Investment
Tesla (NASDAQ:TSLA) saw UBS upgrade it to Neutral on April 13, keeping a $352 price target, while RBC trimmed its target to $480 but left an Outperform rating unchanged. The upgrades come amid mixed signals: a Q1 production run of 408,000...
UBS Raises Its Price Target on Dana Inc (DAN) to $42
UBS raised its price target on Dana Incorporated to $42 on April 14, up from $40, while maintaining a Buy rating. Barclays had earlier lifted its target to $41, reflecting renewed optimism ahead of Q1 earnings. Dana’s "Dana 2030" roadmap...
UBS Raises Its Price Target on BorgWarner (BWA) to $56
UBS raised its price target on BorgWarner (BWA) to $56 from $55 on April 14, 2026, while keeping a Neutral rating. The bank said the stock’s valuation looks more reasonable after a cautious stance following the Q4 results and 2026...
Here Is Why Aptiv (APTV) Is Among the 12 Best EV Stocks to Buy For Long Term Investment
Goldman Sachs reinstated coverage of Aptiv PLC with a Buy rating and a $74 price target after the company spun off its Electrical Distribution Systems unit into Versigent. Wells Fargo, while lowering its target to $81, kept an Overweight stance,...
JPMorgan Downgrades EVgo (EVGO) to Neutral From Overweight
On March 25, 2026 JPMorgan downgraded EVgo (NASDAQ:EVGO) to Neutral from Overweight after assuming coverage, citing a lack of near‑term catalysts and slow margin expansion. The firm expects profitability to stay subdued through at least Q3, despite EVgo’s recurring‑revenue model...
Is VinFast (VFS) the Best EV Stock to Buy For Long Term Investment?
VinFast Auto Ltd. (NASDAQ:VFS) reported a 127% year‑over‑year jump in March 2026 deliveries, moving 27,609 EVs in Vietnam and reaching 53,684 units for the first quarter. The Limo Green and VF 3 were the top‑selling models, together accounting for over 22,000 deliveries...
Stantec Inc. (STN) Selected by European Investment Bank for Climate Adaption Advisory
On April 7, Stantec Inc. was chosen by the European Investment Bank to provide advisory services on climate adaptation, resilience and nature‑based solutions under the EU’s InvestEU Advisory Hub. The firm will assess technical, environmental and financial viability of projects,...
Dycom Industries (DY) Offers Attractive Entry Point Following Stock Selloff
Dycom Industries (NYSE:DY) was added to Wells Fargo’s second‑quarter Tactical Ideas List on April 1, receiving an Overweight rating and a $500 price target. The analyst highlighted a roughly 20% sell‑off since March 1 as an overreaction to the company’s record FY 2026...
Here Is Why Construction Partners (ROAD) Is One of the Best Construction & Engineering Names to Invest In
Construction Partners Inc. (NASDAQ:ROAD) was upgraded by B. Riley on April 2, moving its rating from Neutral to Buy and lifting the price target from $117 to $135 after a 20% stock dip tied to crude‑oil concerns. The firm highlighted that...
WillScot Holdings (WSC) Offers Upside Despite Subdued Rental Units
WillScot Holdings (WSC) received a neutral rating from UBS on April 8, with a $19 price target, citing subdued near‑term earnings. Citi trimmed its target from $26 to $23 on March 9 but maintained a Buy rating, leaving more than 23% upside...
APi Group (APG) Shows Commitment Towards AI-Related Initiatives
APi Group Corp. outlined an aggressive growth plan at JPMorgan’s Industrials Conference, targeting over $10 billion in revenue by 2028. The strategy hinges on achieving 60% recurring revenue and more than a 16% adjusted EBITDA margin. A $125 million cost‑saving program in...
What Makes Valmont Industries (VMI) Appear so Attractive
Valmont Industries (NYSE:VMI) is highlighted as one of the top construction and engineering stocks, with a strongly bullish consensus as of the April 10 close. Four analysts cover the name, three assigning Buy ratings and one a Hold. Management outlined a...
Caltrans Awards Major Infrastructure Contract to Granite Construction (GVA)
Granite Construction Inc. (NYSE:GVA) secured a $114 million contract from Caltrans to build Segment 4E North of the Highway 101 Carpinteria‑to‑Santa Barbara corridor. The company will serve as the primary construction manager for the fourth phase of the project, following a prior award for...
AECOM (ACM) Is One of the Best Construction & Engineering Stocks to Buy, Here Is Why
AECOM (NYSE: ACM) is highlighted as one of Wall Street’s eight top construction and engineering stocks. The firm secured an indefinite‑delivery contract with the U.S. Missile Defense Agency under the SHIELD strategy, tapping a $151 billion defense budget. It also won...
Microsoft (MSFT) Price Target Lowered by $103 Ahead of Q3 Report
BNP Paribas analyst Stefan Slowinski lowered Microsoft’s price target on April 10 from $659 to $556, while keeping an Outperform rating. The new target still suggests roughly a 50% upside from the current share price and comes ahead of Microsoft’s...